Skip to content
  • Sunday, 26 July 2026
  • 2:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1288: Clinical update with Dr. Daniel Griffin
Microbiology & Immunology

TWiV 1288: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 10, 2026 0

In his latest weekly clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello, expressed significant concern and bewilderment regarding recent pronouncements…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 8, 2026 0

In a comprehensive clinical update delivered on the popular podcast "This Week in Virology" (TWiV), Dr. Daniel Griffin, a seasoned…

Read More
Microbiology & Immunology

TWiV 1292: Clinical Update with Dr. Daniel Griffin

Lina Irawan Jul 8, 2026 0

In a stark assessment of the current public health landscape, Dr. Daniel Griffin, in his weekly clinical update on "This…

Read More
Microbiology & Immunology

TWiV 1284: Clinical Update with Dr. Daniel Griffin

Lina Irawan Jul 3, 2026 0

In a timely post-New Year’s Day recording, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) delivered…

Read More
Microbiology & Immunology

TWiV 1286: Clinical update with Dr. Daniel Griffin

Lina Irawan Jul 3, 2026 0

In a recent weekly clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed significant…

Read More
Microbiology & Immunology

TWiV 1288: Clinical Update with Dr. Daniel Griffin

Lina Irawan Jul 2, 2026 0

In a recent clinical update delivered by Dr. Daniel Griffin and Vincent Racaniello on the "This Week in Virology" (TWiV)…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 29, 2026 0

In a comprehensive clinical update presented on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, alongside host Vincent…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 28, 2026 0

In a stark assessment of the current state of public health in the United States, Dr. Daniel Griffin and Vincent…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 23, 2026 0

In a post-New Year’s Eve recording, Dr. Daniel Griffin and Vincent Racaniello of "This Week in Virology" (TWiV) offered a…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Childhood Immunization Schedules Amidst Public Health Data

Lina Irawan Jun 22, 2026 0

In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound bewilderment…

Read More

Posts pagination

1 2 3 … 9
TWiV 1292: Clinical Update with Dr. Daniel Griffin Explores Critical Decline in American Public Health and Global Health SecurityThe Century of Cobalamin: Why a Microscopic Nutrient Remains Essential to Modern Medicine and Mitochondrial HealthScience News: A Century of Illuminating the Frontiers of KnowledgeMitochondria Can Draw Molecular Oxygen Away from Chloroplasts, Unlocking New Insights into Plant Stress Response
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ